High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 4, 2007, Pages 359.e1-359.e6

  Alonso, Immaculada ^a   Torné, Aureli ^a   Puig Tintoré, Luis M ^a   Esteve, Roser ^a   Quinto, Llorenç ^a   Garcia, Sonia ^a   Campo, Elias ^a   Pahisa, Jaume ^a   Ordi, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cervical intraepithelial neoplasia grade 1; high risk human papillomavirus testing; loop electrosurgical excision procedure

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RISK; COLPOSCOPY; ELECTROSURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

EID: 34648813724     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.01.023     Document Type: Article

References (27)

1. Ordi J., Puig-Tintore L.M., Torne A., et al. Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix. Med Clin (Barc) 121 (2003) 441-445
2. Moscicki A.B., Shiboski S., Hills N.K., et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 364 (2004) 1678-1683
3. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Patol 12 (1993) 186-192
4. American College of Obstetricians and Gynecologists. Management of abnormal cervical cytology and histology. ACOG Practice Bulletin, No. 66. Obstet Gynecol 106 (2005) 645-663
5. Wright T.C., Cox J.C., Massad L.S., Carlson J., Twiggs L.B., and Wilkinson E.J. 2001 Consensus Guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 189 (2003) 295-30
6. Solomon D., Schiffman M., and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. ALTS Study Group. J Natl Cancer Inst 93 (2001) 293-299
7. Cox J.T., Schiffman M., Solomon D., and ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188 (2003) 1406-1412
8. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
9. Bosch F.X., Lorincz A.T., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002) 244-265
10. Moscicki A.B., Schiffman M., Kjaer S., and Villa L.L. Updating the natural history of HPV and anogenital cancer. Vaccine 24 (2006) 42-51
11. Law K.S., Chang T.C., Hsueh S., Jung S.M., Tseng C.J., and Lai C.H. High prevalence of high grade squamous intraepithelial lesions and microinvasive carcinoma in women with a cytologic diagnosis of low grade squamous intraepithelial lesions. J Reprod Med 46 (2001) 61-64
12. Torné A., Puig-Tintoré L.M., Jou P., et al. [Concordancia diagnóstica entre citología, colposcopia y pequeña biopsia en pacientes con lesiones escamosas del cérvix uterino]. Prog Obstet Ginecol 39 (1996) 520-528
13. Puig-Tintoré L.M., Alba A., Bosch F.X., et al. [La infección por papilomavirus. Documento de consenso de la SEGO, SEC y AEPCC] (2003), Meditex-Sanex, Madrid 41-104 Documentos de Consenso SEGO 2002, ed.
14. Spitzer M., Apgar B., and Brotzman G. Management of histologic abnormalities of the cervix. Am Fam Physician 73 (2006) 105-112
15. Alonso I., Torné A., Puig-Tintoré L.M., et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 103 (2006) 631-636
16. Ordi J., Alonso I., Torné A., et al. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test?. Gynecol Oncol 99 (2005) 313-319
17. Wright T.C., Kurman R.J., and Ferenczy A. Precancerous lesions of the cervix. In: Kurman R.J. (Ed). Blaustein's pathology of the female genital tract. 5th ed. (2002), Springer-Verlag, New York 253-324
18. Ylitalo N., Sorensen P., Josefsson A.M., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
19. Moberg M., Gustavsson I., Wilander E., and Gyllensten U. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 92 (2005) 891-894
20. Josefsson A.M., Magnusson P.K., Ylitalo N., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
21. Castle P.E., Schiffman M., Scott D.R., et al. Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1311-1314
22. Clavel C., Bory J.P., Caudroy S., et al. Usefulness of HPV testing in the follow-up of untreated cervical low grade lesions. Histol Histopathol 20 (2005) 1085-1091
23. Sarian L.O., Derchain S.F., Pittal Dda R., Andrade L.A., Morais S.S., and Figuereido P.G. Human papillomavirus detection by hybrid capture II and residual or recurrent high-grade squamous cervical intraepithelial neoplasia after large loop excision of the transformation zone (LEEP). Tumori 91 (2005) 188-192
24. Song S.H., Lee J.K., Oh M.J., Na J.Y., Park Y.K., and Saw H.S. Persistent HPV infection after conization in patients with negative margins. Gynecol Oncol 101 (2006) 418-422
25. Paraskevaidis E., Koliopoulos G., Alamanos Y., Malamou-Mitsi V., Lolis E.D., and Kitchener H.C. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol 98 (2001) 833-836
26. Zielinski G.D., Bais A.G., Helmerhorst T.J., et al. HPV Testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis. Obstet Gynecol Surv 59 (2004) 543-553
27. Nobbenhuis M., Meijer C., van den Brule A., et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84 (2001) 796-801